logo
Select company
Select metric
30.44%Capital Expenditures Margin
VS
Market
10
Sector
10
Industry
19
History
41
$ 0.8Close
$ 0.68 - $ 2.3 52-Week Range
Ticker Information

Ticker

LGVN

Company Name

LONGEVERON INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LONGEVERON INC - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LGVN - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 631K30.44%$ 2.07M
3/31/2025$ 666K29.93%$ 2.23M
12/31/2024$ 655K27.38%$ 2.39M
9/30/2024$ 806K43.52%$ 1.85M
6/30/2024$ 379K30.84%$ 1.23M
3/31/2024$ 275K28.12%$ 978K
12/31/2023$ 301K42.45%$ 709K
9/30/2023$ 203K26.47%$ 767K
6/30/2023$ 578K65.53%$ 882K
3/31/2023$ 564K49.87%$ 1.13M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LONGEVERON INC's latest trailing twelve months (TTM) CapEx % stands at 0.67%.
  • Over the past 5 years, LONGEVERON INC's average CapEx % has been 30.57%.
  • The median CapEx % for LONGEVERON INC during this period was 29.45%
  • LONGEVERON INC reached its highest CapEx % over the past 5 years at 65.53%.
  • The lowest CapEx % recorded by LONGEVERON INC in the same timeframe 0.23%

LONGEVERON INC's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
CYCN : CYCLERION THERAPEUTICS INC -TRAW : TRAWS PHARMA INC -LYRA : LYRA THERAPEUTICS INC -ERNA : ERNEXA THERAPEUTICS INC 3.89%BRTX : BIORESTORATIVE THERAPIES INC 17.73%APRE : APREA THERAPEUTICS INC -XBIO : XENETIC BIOSCIENCES INC -TXMD : THERAPEUTICSMD INC -LUCY : INNOVATIVE EYEWEAR INC 3.39%LEXX : LEXARIA BIOSCIENCE CORP 10.98%

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for LONGEVERON INC is calculated as follows: CapEx [ $ 37.57K ] / Revenues [ $ 5.64M ]
(=) CapEx % [ 0.67% ]

LGVN - Capital Expenditures Margin, Last 5 years

0.23%

Minimum

Sep 30, 2021

65.53%

Maximum

Jun 30, 2023

30.57%

Average

29.45%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.47% with a standard deviation of 3.28%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.04%
average3.47%
median2.43%
std3.28%